相似文献
1
Identification and Optimization of 4-Anilinoquinolines as Inhibitors of Cyclin G Associated Kinase.
ChemMedChem. 2018 Jan 8;13(1):48-66. doi: 10.1002/cmdc.201700663. Epub 2017 Nov 27.
2
Design and Analysis of the 4-Anilinoquin(az)oline Kinase Inhibition Profiles of GAK/SLK/STK10 Using Quantitative Structure-Activity Relationships.
ChemMedChem. 2020 Jan 7;15(1):26-49. doi: 10.1002/cmdc.201900521. Epub 2019 Nov 26.
3
Targeting the Water Network in Cyclin G-Associated Kinase (GAK) with 4-Anilino-quin(az)oline Inhibitors.
ChemMedChem. 2020 Jul 3;15(13):1200-1215. doi: 10.1002/cmdc.202000150. Epub 2020 May 26.
4
Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in Chordoma.
J Med Chem. 2019 May 9;62(9):4772-4778. doi: 10.1021/acs.jmedchem.9b00350. Epub 2019 Apr 19.
5
Discovery of a Potent Dual SLK/STK10 Inhibitor Based on a Maleimide Scaffold.
J Med Chem. 2021 Sep 23;64(18):13259-13278. doi: 10.1021/acs.jmedchem.0c01579. Epub 2021 Aug 31.
6
4-Anilino-6-phenyl-quinoline inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK2).
Bioorg Med Chem Lett. 2010 Aug 15;20(16):4738-40. doi: 10.1016/j.bmcl.2010.06.107. Epub 2010 Jun 25.
7
Optimization of Isothiazolo[4,3- b]pyridine-Based Inhibitors of Cyclin G Associated Kinase (GAK) with Broad-Spectrum Antiviral Activity.
J Med Chem. 2018 Jul 26;61(14):6178-6192. doi: 10.1021/acs.jmedchem.8b00613. Epub 2018 Jul 16.
8
Selective Inhibitors of Cyclin G Associated Kinase (GAK) as Anti-Hepatitis C Agents.
J Med Chem. 2015 Apr 23;58(8):3393-410. doi: 10.1021/jm501759m. Epub 2015 Apr 9.
9
Synthesis, biological evaluation and molecular modelling studies of 4-anilinoquinazoline derivatives as protein kinase inhibitors.
Bioorg Med Chem. 2014 Mar 15;22(6):1909-15. doi: 10.1016/j.bmc.2014.01.044. Epub 2014 Jan 31.
10
Discovery of 3-phenyl- and 3-N-piperidinyl-isothiazolo[4,3-b]pyridines as highly potent inhibitors of cyclin G-associated kinase.
Eur J Med Chem. 2021 Mar 5;213:113158. doi: 10.1016/j.ejmech.2021.113158. Epub 2021 Jan 12.
引用本文的文献
1
PIP4K2C inhibition reverses autophagic flux impairment induced by SARS-CoV-2.
Nat Commun. 2025 Jul 10;16(1):6397. doi: 10.1038/s41467-025-61759-1.
2
PIP4K2C inhibition reverses autophagic flux impairment induced by SARS-CoV-2.
bioRxiv. 2024 Apr 17:2024.04.15.589676. doi: 10.1101/2024.04.15.589676.
3
Discovery and optimization of narrow spectrum inhibitors of Tousled like kinase 2 (TLK2) using quantitative structure activity relationships.
Eur J Med Chem. 2024 May 5;271:116357. doi: 10.1016/j.ejmech.2024.116357. Epub 2024 Apr 2.
4
Synthesis of a 3,7-Disubstituted Isothiazolo[4,3-]pyridine as a Potential Inhibitor of Cyclin G-Associated Kinase.
Molecules. 2024 Feb 22;29(5):954. doi: 10.3390/molecules29050954.
5
Discovery and Optimization of Narrow Spectrum Inhibitors of Tousled Like Kinase 2 (TLK2) Using Quantitative Structure Activity Relationships.
bioRxiv. 2023 Dec 28:2023.12.28.573261. doi: 10.1101/2023.12.28.573261.
6
Utilization of Supervised Machine Learning to Understand Kinase Inhibitor Toxophore Profiles.
Int J Mol Sci. 2023 Mar 7;24(6):5088. doi: 10.3390/ijms24065088.
7
Optimization of the 4-anilinoquin(az)oline scaffold as epidermal growth factor receptor (EGFR) inhibitors for chordoma utilizing a toxicology profiling assay platform.
Sci Rep. 2022 Jul 27;12(1):12820. doi: 10.1038/s41598-022-15552-5.
8
Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies.
Antiviral Res. 2022 Aug;204:105367. doi: 10.1016/j.antiviral.2022.105367. Epub 2022 Jun 20.
9
Identification of 4-Anilinoquin(az)oline as a Cell-Active Protein Kinase Novel 3 (PKN3) Inhibitor Chemotype.
ChemMedChem. 2022 Jun 20;17(12):e202200161. doi: 10.1002/cmdc.202200161. Epub 2022 May 9.
10
Optimization of 4-Anilinoquinolines as Dengue Virus Inhibitors.
Molecules. 2021 Dec 3;26(23):7338. doi: 10.3390/molecules26237338.
本文引用的文献
1
Progress towards a public chemogenomic set for protein kinases and a call for contributions.
PLoS One. 2017 Aug 2;12(8):e0181585. doi: 10.1371/journal.pone.0181585. eCollection 2017.
2
The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 Kinase.
J Med Chem. 2016 May 26;59(10):4867-80. doi: 10.1021/acs.jmedchem.6b00211. Epub 2016 May 4.
3
The Emergence of Zika Virus as a Global Health Security Threat: A Review and a Consensus Statement of the INDUSEM Joint working Group (JWG).
J Glob Infect Dis. 2016 Jan-Mar;8(1):3-15. doi: 10.4103/0974-777X.176140.
4
Endocytic control of signaling at the plasma membrane.
Curr Opin Cell Biol. 2016 Apr;39:21-7. doi: 10.1016/j.ceb.2016.01.012. Epub 2016 Feb 10.
5
Family-wide Structural Analysis of Human Numb-Associated Protein Kinases.
Structure. 2016 Mar 1;24(3):401-11. doi: 10.1016/j.str.2015.12.015. Epub 2016 Feb 4.
6
Target engagement and drug residence time can be observed in living cells with BRET.
Nat Commun. 2015 Dec 3;6:10091. doi: 10.1038/ncomms10091.
7
KLIFS: a structural kinase-ligand interaction database.
Nucleic Acids Res. 2016 Jan 4;44(D1):D365-71. doi: 10.1093/nar/gkv1082. Epub 2015 Oct 22.
8
Application of BRET to monitor ligand binding to GPCRs.
Nat Methods. 2015 Jul;12(7):661-663. doi: 10.1038/nmeth.3398. Epub 2015 Jun 1.
9
NanoBRET--A Novel BRET Platform for the Analysis of Protein-Protein Interactions.
ACS Chem Biol. 2015 Aug 21;10(8):1797-804. doi: 10.1021/acschembio.5b00143. Epub 2015 Jun 9.
10
FDA-approved small-molecule kinase inhibitors.
Trends Pharmacol Sci. 2015 Jul;36(7):422-39. doi: 10.1016/j.tips.2015.04.005. Epub 2015 May 12.
Zotero 插件